Kou; Jim H.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kou; Jim H..The latest application filed is for "controlled release formulations of levodopa and uses thereof".

Company Profile

0.14.18

Kou; Jim H. - San Jose CA
Kou; Jim H. - Basking Ridge NJ
Kou; Jim H. - Palo Alto CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Controlled release formulations of levodopa and uses thereof Grant 9,463,246 - Hsu , et al. October 11, 2	2016-10-11
Controlled release formulations of levodopa and uses thereof Grant 9,089,607 - Hsu , et al. July 28, 2	2015-07-28
Controlled release formulations of levodopa and uses thereof Grant 9,089,608 - Hsu , et al. July 28, 2	2015-07-28
Controlled Release Formulations Of Levodopa And Uses Thereof App 20140024718 - Hsu; Ann ; et al.	2014-01-23
Controlled Release Formulations Of Levodopa And Uses Thereof App 20140018425 - Hsu; Ann ; et al.	2014-01-16
Controlled release formulations of levodopa and uses thereof Grant 8,557,283 - Hsu , et al. October 15, 2	2013-10-15
Controlled Release Formulations Of Levodopa And Uses Thereof App 20130259932 - Hsu; Ann ; et al.	2013-10-03
Controlled release formulations of levodopa and uses thereof Grant 8,454,998 - Hsu , et al. June 4, 2	2013-06-04
Controlled Release Formulations Of Levodopa And Uses Thereof App 20130102676 - Hsu; Ann ; et al.	2013-04-25
Gastroretentive Solid Oral Dosage Forms with Swellable Hydrophilic Polymer App 20130064896 - Alani; Laman Lynn ; et al.	2013-03-14
Controlled release formulations of levodopa and uses thereof Grant 8,377,474 - Hsu , et al. February 19, 2	2013-02-19
Controlled Release Formulations Of Levodopa And Uses Thereof App 20120177731 - Hsu; Ann ; et al.	2012-07-12
Pharmaceutical formulations and compositions of a selective antagonist of either CXCR2 or both CXCR1 and CXCR2 and methods of using the same for treating inflammatory disorders Grant 8,183,287 - Kou , et al. May 22, 2	2012-05-22
Pharmaceutical Compositions App 20110207740 - Heimbecher; Susan K. ; et al.	2011-08-25
Controlled Release Formulations Of Levodopa And Uses Thereof App 20100298268 - Hsu; Ann ; et al.	2010-11-25
Stable extended release oral dosage composition Grant 7,820,199 - Kou October 26, 2	2010-10-26
Pharmaceutical Compositions App 20080293734 - Heimbecher; Susan K. ; et al.	2008-11-27
Pharmaceutical Formulations and Compositions of a Selective Antagonist of Either CXCR2 or Both CXCR1 and CXCR2 and Methods of Using the Same for Treating Inflammatory Disorders App 20080021100 - Kou; Jim H. ; et al.	2008-01-24
Stable extended release oral dosage composition App 20060159761 - Kou; Jim H.	2006-07-20
Pharmaceutical compositions App 20060009504 - Heimbecher; Susan K. ; et al.	2006-01-12
Stable extended release oral dosage composition Grant 6,979,463 - Kou December 27, 2	2005-12-27
Stable extended release oral dosage composition App 20030086971 - Kou, Jim H.	2003-05-08
8-chloro-6,11-dihydro-11- ] (4-piperidylidine)-5H-benzo[5,6]cyclohepta[1,2-bpyridine oral compositions Grant 6,100,274 - Kou August 8, 2	2000-08-08
Controlled delivery of pharmaceuticals from preformed porous polymeric microparticles Grant 5,470,582 - Supersaxo , et al. November 28, 1	1995-11-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.